
Keywords: Multiple myeloma; Pharmacologically-dosed ascorbic acid; Apoptosis-inducing factor 1; MM; multiple myeloma; ROS; reactive oxygen species; SMM; smoldering MM; IMIDs; immunomodulatory drugs; ASCT; autologous stem cell transplantation; CRs; complete remissio